Charming Medical Limited Class A(MCTA)
$29.360.00 (0.00%)
MCTA
Charming Medical Limited Class A financials statements
$29.36
At close:0.00 (0.00%)
Charming Medical Limited Class A (MCTA) Ratios
38 Followers
Charming Medical Limited Class A Ratios
MCTA's free cash flow for Q? was ―. For the fiscal year, MCTA's free cash flow was increased by ― and operating cash flow was ―. See a summary of the company’s cash flow.
| Ratios | Mar 25 | Mar 24 | Mar 23 |
|---|---|---|---|
| Liquidity Ratios | |||
| Current Ratio | 0.68 | 0.62 | 0.57 |
| Quick Ratio | 0.68 | 0.62 | 0.57 |
| Cash Ratio | 0.17 | 0.36 | 0.27 |
| Solvency Ratio | 0.28 | 0.19 | -0.01 |
| Operating Cash Flow Ratio | 0.09 | 0.05 | 0.34 |
| Short-Term Operating Cash Flow Coverage | 1.36 | 0.67 | 4.13 |
| Net Current Asset Value | $ -1.94M | $ -2.36M | $ -3.53M |
| Leverage Ratios | |||
| Debt-to-Assets Ratio | 0.22 | 0.20 | 0.28 |
| Debt-to-Equity Ratio | 23.57 | -0.89 | -1.56 |
| Debt-to-Capital Ratio | 0.96 | -8.14 | 2.78 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 108.76 | -4.52 | -5.51 |
| Debt Service Coverage Ratio | 4.43 | 2.64 | -0.17 |
| Interest Coverage Ratio | 66.54 | 38.73 | -25.73 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.07 | 0.06 | 0.11 |
| Net Debt to EBITDA | 0.20 | -0.80 | 0.63 |
| Profitability Margins | |||
| Gross Profit Margin | 67.19% | 65.07% | 42.31% |
| EBIT Margin | 23.40% | 17.12% | -11.33% |
| EBITDA Margin | 27.64% | 23.63% | -5.36% |
| Operating Profit Margin | 22.32% | 16.77% | -14.77% |
| Pretax Profit Margin | 23.07% | 16.68% | -11.91% |
| Net Profit Margin | 19.27% | 12.93% | -8.64% |
| Continuous Operations Profit Margin | 19.27% | 13.66% | -9.51% |
| Net Income Per EBT | 83.55% | 77.51% | 72.57% |
| EBT Per EBIT | 103.33% | 99.47% | 80.65% |
| Return on Assets (ROA) | 22.39% | 15.93% | -4.78% |
| Return on Equity (ROE) | 2435.04% | -72.06% | 26.33% |
| Return on Capital Employed (ROCE) | 341.03% | -101.11% | 66.45% |
| Return on Invested Capital (ROIC) | 95.92% | -447.31% | -76.96% |
| Return on Tangible Assets | 22.39% | 15.93% | -4.78% |
| Earnings Yield | 1.01% | 0.66% | -0.26% |
| Efficiency Ratios | |||
| Receivables Turnover | 10.74 | 3.92 | 1.66 |
| Payables Turnover | 586.60 | 0.00 | 1295.76 |
| Inventory Turnover | 76.18 | 74.65 | 30.71 |
| Fixed Asset Turnover | 5.14 | 6.53 | 1.96 |
| Asset Turnover | 1.16 | 1.23 | 0.55 |
| Working Capital Turnover Ratio | -3.28 | -2.29 | 0.00 |
| Cash Conversion Cycle | 38.14 | 98.07 | 231.21 |
| Days of Sales Outstanding | 33.97 | 93.18 | 219.61 |
| Days of Inventory Outstanding | 4.79 | 4.89 | 11.89 |
| Days of Payables Outstanding | 0.62 | 0.00 | 0.28 |
| Operating Cycle | 38.76 | 98.07 | 231.49 |
| Cash Flow Ratios | |||
| Operating Cash Flow Per Share | 0.03 | 0.02 | 0.14 |
| Free Cash Flow Per Share | 0.01 | 0.01 | 0.11 |
| Dividend Paid and CapEx Coverage Ratio | 1.48 | 1.40 | 4.01 |
| Capital Expenditure Coverage Ratio | 1.48 | 1.40 | 4.01 |
| Operating Cash Flow Coverage Ratio | 0.37 | 0.31 | 1.35 |
| Operating Cash Flow to Sales Ratio | 0.07 | 0.05 | 0.69 |
| Free Cash Flow Yield | 0.12% | 0.07% | 1.54% |
| Valuation Ratios | |||
| Price-to-Earnings (P/E) Ratio | 98.87 | 152.44 | -388.59 |
| Price-to-Sales (P/S) Ratio | 19.06 | 19.71 | 33.58 |
| Price-to-Book (P/B) Ratio | 2407.77 | -109.84 | -102.33 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 856.93 | 1397.67 | 64.87 |
| Price-to-Operating Cash Flow Ratio | 278.40 | 401.34 | 48.72 |
| Price-to-Earnings Growth (PEG) Ratio | 1.82 | -0.43 | 0.00 |
| Enterprise Value Multiple | 69.15 | 82.62 | -626.27 |
| Enterprise Value | 118.91M | 117.42M | 118.45M |
| EV to EBITDA | 69.15 | 82.62 | -626.27 |
| EV to Sales | 19.11 | 19.52 | 33.55 |
| EV to Free Cash Flow | 859.42 | 1384.21 | 64.81 |
| EV to Operating Cash Flow | 279.20 | 397.47 | 48.67 |
| Tangible Book Value Per Share | 0.00 | -0.07 | -0.07 |
| Shareholders’ Equity Per Share | 0.00 | -0.06 | -0.07 |
| Tax and Other Ratios | |||
| Effective Tax Rate | 0.16 | 0.18 | 0.20 |
| Revenue Per Share | 0.37 | 0.36 | 0.21 |
| Net Income Per Share | 0.07 | 0.05 | -0.02 |
| Tax Burden | 0.84 | 0.78 | 0.73 |
| Interest Burden | 0.99 | 0.97 | 1.05 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.37 | 0.25 | 0.28 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.36 | 0.36 | -7.25 |
Currency in USD
